Evidence map›Paper›PMID 37569837›Full record

ReviewInternational journal of molecular sciences2023

An Update on Toll-like Receptor 2, Its Function and Dimerization in Pro- and Anti-Inflammatory Processes.

Katrin Colleselli, Anna Stierschneider, Christoph Wiesner

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Biomolecules · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Katrin ColleselliDepartment of Medical and Pharmaceutical Biotechnology, IMC University of Applied Sciences, 3500 Krems, Austria.ORCID 0009-0002-3570-9813
Anna StierschneiderDepartment of Medical and Pharmaceutical Biotechnology, IMC University of Applied Sciences, 3500 Krems, Austria.ORCID 0000-0002-6963-8956
Christoph WiesnerDepartment of Medical and Pharmaceutical Biotechnology, IMC University of Applied Sciences, 3500 Krems, Austria.ORCID 0000-0002-3281-0695
IMC University of Applied Sciences Krems · AT

Funding

Austrian Research Promotion Agency (FFG) 35467434FTI Program K3-F-744/005-2019
6 · The paper itself

Abstract

While a certain level of inflammation is critical for humans to survive infection and injury, a prolonged inflammatory response can have fatal consequences. Pattern recognition Toll-like receptors (TLRs) are key players in the initiation of an inflammatory process. TLR2 is one of the most studied pattern recognition receptors (PRRs) and is known to form heterodimers with either TLR1, TLR4, TLR6, and TLR10, allowing it to recognize a wide range of pathogens. Although a large number of studies have been conducted over the past decades, there are still many unanswered questions regarding TLR2 mechanisms in health and disease. In this review, we provide an up-to-date overview of TLR2, including its homo- and heterodimers. Furthermore, we will discuss the pro- and anti-inflammatory properties of TLR2 and recent findings in prominent TLR2-associated infectious and neurodegenerative diseases.

Indexed as

Toll-Like Receptor 1Toll-Like Receptor 2Anti-Inflammatory AgentsDimerizationHumansToll-Like Receptor 10Toll-Like Receptor 6Toll-Like ReceptorsAnti-Inflammatory AgentsToll-Like Receptor 1Toll-Like Receptor 10Toll-Like Receptor 2Toll-Like Receptor 6Toll-Like ReceptorsdimerizationheterodimerizationhomodimerizationinflammationneurodegenerationneuroinflammationToll-like receptor 2

Identifiers

PMID37569837
PMCPMC10419760
OpenAlexW4385606298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.